15.61 USD
↗ 3.41 (27.94%)AT CLOSE (03:59 PM EST)
Mentari Therapeutics, Inc. Common Stock
MTRINASDAQ • USD
15.00
↘ 0.61 (3.90%)
POST MARKET (AS OF 05:40 PM EST)
Post Market
AS OF 05:40 PM EST
15.00
↘ 0.61 (3.90%)
Market: OPEN
Mentari Therapeutics, Inc. Common Stock (MTRI) trades at $15.00 per share. Technical indicators currently signal "Sell". Notable factors include a bullish Golden Cross on the moving averages.
Technical & fundamental data as of Nov 11, 2026.
Open?$12.50
High?$16.50
Low?$12.50
Prev. Close?$12.20
Volume?60.0K
Avg. Volume?N/A
VWAP?$14.66
Bid / Ask
Bid?$14.00 × 300
Ask?$16.58 × 200
Spread?$2.58
Midpoint?$15.29
Valuation & Ratios
Market Cap?711.3M
Shares Out?N/A
Float?5.4M
Float %?99.2%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
Mentari Therapeutics Inc is a biotechnology company engaged in the development of therapies for the prevention of migraine. Its product pipeline includes MT-001, an anti-PACAP monoclonal antibody, and MT-002, a bispecific antibody targeting both CGRP and PACAP pathways. The company's research and development activities focus on therapeutic candidates targeting PACAP and CGRP-related mechanisms for migraine prevention.
Employees
N/A
Market Cap
711.3M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2026-11-09
Address
C/O NORTON ROSE FULBRIGHT CANADA LLP
VANCOUVER, V6B 0M3
Phone: (604) 669-7207
VANCOUVER, V6B 0M3
Phone: (604) 669-7207
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental Outlook
Loading...
Short InterestLow
Short % of Float?0.15%Low
Short Interest?8.3K
Days to Cover?1.0
Free Float5.4M
Avg Daily Volume572.3K
Settlement Date2022-09-15